Vanda Pharmaceuticals Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VNDA | ANRO | NMRA | NRXP | MPLT | OVID | |
|---|---|---|---|---|---|---|
| Market cap | 274.50M | 947.70M | 82.17M | 123.39M | 477.95M | 470.67M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 22.7 | -7.4 | -0.7 | -8.1 | -2.5 | -6.4 |
| Price/book | 1.2 | 3.9 | 1.8 | -712.5 | 1.1 | 2.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −12.62% | +329.72% | −74.41% | −8.65% | −51.85% | +55.70% |
| Today | −0.66% | −0.90% | −8.07% | 0.00% | −2.60% | −2.03% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All VNDA news ›Competition: Vanda Pharmaceuticals Mallorca Women’s Championships presented by Ecotrans Group 2026 Women’s Singles
The Past, Present and Future of tennis Vanda Pharmaceuticals Mallorca Women's Championships presented by Ecotrans Group 2026 Women's Singles
Vanda Pharmaceuticals: Millennium reports 7% stake
Three parties report a shared stake with no sole voting power in Vanda Pharmaceuticals (VNDA). Stock Titan - [SCHEDULE 13G/A] Vanda Pharmaceuticals Inc. Amended Passive Investment Disclosure Vanda Pharmaceuticals: Millennium reports 7%…
Vanda Pharmaceuticals Announces Presentation at 2026 EADV Annual Meeting
Oct 02, 2026, 09:06 ET WASHINGTON, Oct. 2, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced participation at the European Academy of Dermatology and Venereology (EADV) Annual Meeting, being held in Vienna,…
Vanda Pharmaceuticals Athens Open 2027 Scores | Latest Scores & Live Updates – WTA Official
wtatennis.com Scores Not Available Yet Scores will start appearing once play starts. Check back then! In the meantime, use the year selector to check last years matches, or go to the calendar to explore more tournaments.
Capitals Announce Fan Initiatives Surrounding Capitals Opening Night Presented by Vanda Pharmaceuticals | Washington Capitals
Rock the Red Carpet to Return Next Season Amid Capital One Arena Transformation and F Street Construction As the transformation of Capital One Arena continues, including construction on F Street, the Capitals will not host Rock the Red…
Vanda: 'Hold' On Hetlioz Trial Win, But Several Risk Factors Remain For It (NASDAQ:VNDA)
Vanda Pharma is downgraded to Hold as revenue slips and HETLIOZ faces generics; BYSANTI launch nears but cash runway ends in 2027. Click for more on VNDA stock.
Vanda Pharmaceuticals says HETLIOZ study met endpoint
A 37.1-minute placebo-adjusted shift in sleep onset supports Vanda's plan to seek a third U.S. HETLIOZ indication. A 37.1-minute placebo-adjusted advance in sleep onset marked a positive Phase III result as Vanda Pharmaceuticals Inc.…
Vanda Pharmaceuticals (VNDA) Reports Positive Phase III Results
What is VNDA's GF Score™? VNDA’s GF Score™ is 69 out of 100, reflecting a moderate overall fundamental health with strong valuation but weaknesses in profitability and momentum. Is VNDA overvalued or undervalued? Based on Price-to-Sales,…
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
HETLIOZ® is already an approved circadian regulator. The FDA first approved it in 2014 to treat Non-24-Hour Sleep-Wake Disorder in adults, and in 2020 to treat nighttime sleep disturbances in people with Smith-Magenis Syndrome. The DSWPD…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
gurufocus.com1
-
mugglehead.com1
-
prnewswire.com1
-
seekingalpha.com1
-
stocktitan.net1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.